We help clients derive a broad product development and evaluation master plan and provide guidance regarding necessary liaison between national and international bodies, investors, etc..     Highlights           Development of master plan for clinical drug profiling Development of strategic concept for drug approval Portfolio analysis Evaluation of anticancer compounds for in-licensing Assembly of advisory board Assembly of opinion leader pool Communication with national and international authorities(EMEA/FDA/BfArM etc..) Assistance in preparation of a business concept for investors